Aurore Marie

Director, Cilcare USA & Head Of Operational Excellence at Cilcare

Aurore MARIE is an accomplished professional with extensive experience in research and development operations, particularly in the biotechnology sector. As the Director of CILCARE USA and Head of Operational Excellence since February 2015, Aurore has held various leadership roles including Global Head of R&D Operations Management and Senior Operations Manager, overseeing R&D programs in collaboration with external partners and serving as Principal Investigator for several GLP studies. Earlier roles include project management and engineering positions focused on protocol development, electrophysiological measurements, and behavioral testing related to neurological conditions. Aurore holds a Master's degree in Project Management and Innovation in Biotechnology from the University of Montpellier and a Bachelor's degree from Université de Lorraine.

Location

Montpellier, France

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Cilcare

CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy. CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring. We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.


Employees

11-50

Links